In conclusion, in this study, we demonstrated the critical role of IL-7 in IgG4-RD, finding that administration of exogenous IL-7 could induce the expansion of CD4+CD28- CTLs and CD8+CD28- CTLs in IgG4-RD patients. Here, CD28 is linked to immunoglobulin G4-related sclerosing disease.